KALA
KALA
NASDAQ · Biotechnology

Kala Bio Inc

$1.79
-0.30 (-14.35%)
As of Jun 30, 4:35 PM ET ·
Analyst Consensus
Strong Sell
6
Analysts
Moderate
Coverage
Buy 0 0%
Hold 3 50%
Sell 3 50%
Price Target
Analyst Price Target +525.1% upside
Low Target $8.32
Average Target $11.19
High Target $14.48
Current Price $1.79
Current
$1.79
Target
$11.19
$8.32 $11.19 avg $14.48
Scenario Analysis
Bear Case
$8.32
364.8%
Low target
Base Case
$11.19
+525.1%
Avg target
Bull Case
$14.48
+708.9%
High target
Risk/Reward
1.9x
Balanced
Price in Context
Target vs 52W High
$11.19
-98.9% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 40 78% $257.58 +2.4%
AMGN
Amgen Inc
Hold 44 50% $190.87 -47.2%
GILD
Gilead Sciences Inc
Strong Buy 39 82% $362.68 +187.5%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 40 83% $438.34 -11.4%
REGN
Regeneron Pharmaceuticals
Buy 38 71% $76.80 -87.8%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 37 76% $102.31 -65.6%
RVMD
Revolution Medicines Inc
Strong Buy 27 96% $114.11 -38.5%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -48.0%